1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Latest developments in metal complexes as anticancer agents
(
- Contribution to journal › Scientific review
- 2006
-
Mark
alpha1-Antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release.
(
- Contribution to journal › Article
- 2004
-
Mark
Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
(
- Contribution to journal › Article
-
Mark
αl-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro
(
- Contribution to journal › Article
- 2003
-
Mark
Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
(
- Contribution to journal › Article
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
-
Mark
Multiple effects of alpha(1)-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness
(
- Contribution to journal › Article
- 2002
-
Mark
Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity.
(
- Contribution to journal › Article